Year |
Citation |
Score |
2019 |
Sahu AD, S Lee J, Wang Z, Zhang G, Iglesias-Bartolome R, Tian T, Wei Z, Miao B, Nair NU, Ponomarova O, Friedman AA, Amzallag A, Moll T, Kasumova G, Greninger P, et al. Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy. Molecular Systems Biology. 15: e8323. PMID 30858180 DOI: 10.15252/Msb.20188323 |
0.323 |
|
2017 |
Ducker GS, Ghergurovich JM, Mainolfi N, Suri V, Jeong SK, Hsin-Jung Li S, Friedman A, Manfredi MG, Gitai Z, Kim H, Rabinowitz JD. Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 114: 11404-11409. PMID 29073064 DOI: 10.1073/Pnas.1706617114 |
0.303 |
|
2017 |
Friedman AA, Xia Y, Trippa L, Le LP, Igras V, Frederick DT, Wargo JA, Tanabe KK, Lawrence DP, Neuberg DS, Flaherty KT, Fisher D. Feasibility of ultra-high-throughput functional screening of melanoma biopsies for discovery of novel cancer drug combinations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28446504 DOI: 10.1158/1078-0432.Ccr-16-3029 |
0.378 |
|
2015 |
Friedman AA, Letai A, Fisher DE, Flaherty KT. Precision medicine for cancer with next-generation functional diagnostics. Nature Reviews. Cancer. PMID 26536825 DOI: 10.1038/Nrc4015 |
0.308 |
|
2015 |
Friedman AA, Amzallag A, Pruteanu-Malinici I, Baniya S, Cooper ZA, Piris A, Hargreaves L, Igras V, Frederick DT, Lawrence DP, Haber DA, Flaherty KT, Wargo JA, Ramaswamy S, Benes CH, et al. Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment. Plos One. 10: e0140310. PMID 26461489 DOI: 10.1371/Journal.Pone.0140310 |
0.368 |
|
2013 |
Bergwitz C, Wee MJ, Sinha S, Huang J, DeRobertis C, Mensah LB, Cohen J, Friedman A, Kulkarni M, Hu Y, Vinayagam A, Schnall-Levin M, Berger B, Perkins LA, Mohr SE, et al. Genetic determinants of phosphate response in Drosophila. Plos One. 8: e56753. PMID 23520455 DOI: 10.1371/Journal.Pone.0056753 |
0.447 |
|
2011 |
Friedman AA, Tucker G, Singh R, Yan D, Vinayagam A, Hu Y, Binari R, Hong P, Sun X, Porto M, Pacifico S, Murali T, Finley RL, Asara JM, Berger B, et al. Proteomic and functional genomic landscape of receptor tyrosine kinase and ras to extracellular signal-regulated kinase signaling. Science Signaling. 4: rs10. PMID 22028469 DOI: 10.1126/Scisignal.2002029 |
0.615 |
|
2011 |
Friedman AA, Perrimon N, VanHook AM. Science Signaling Podcast: 25 October 2011 Science Signaling. 4: pc22-pc22. DOI: 10.1126/Scisignal.2002560 |
0.517 |
|
2009 |
Yang X, Friedman A, Nagpal S, Perrimon N, Asara JM. Use of a label-free quantitative platform based on MS/MS average TIC to calculate dynamics of protein complexes in insulin signaling. Journal of Biomolecular Techniques : Jbt. 20: 272-7. PMID 19949701 |
0.34 |
|
2009 |
Kaplow IM, Singh R, Friedman A, Bakal C, Perrimon N, Berger B. RNAiCut: automated detection of significant genes from functional genomic screens. Nature Methods. 6: 476-7. PMID 19564846 DOI: 10.1038/Nmeth0709-476 |
0.616 |
|
2007 |
Friedman A, Perrimon N. Genetic screening for signal transduction in the era of network biology. Cell. 128: 225-31. PMID 17254958 DOI: 10.1016/J.Cell.2007.01.007 |
0.52 |
|
2007 |
Perrimon N, Friedman A, Mathey-Prevot B, Eggert US. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens. Drug Discovery Today. 12: 28-33. PMID 17198970 DOI: 10.1016/J.Drudis.2006.10.006 |
0.503 |
|
2006 |
Friedman A, Perrimon N. A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling. Nature. 444: 230-4. PMID 17086199 DOI: 10.1038/Nature05280 |
0.573 |
|
2006 |
Kulkarni MM, Booker M, Silver SJ, Friedman A, Hong P, Perrimon N, Mathey-Prevot B. Evidence of off-target effects associated with long dsRNAs in Drosophila melanogaster cell-based assays. Nature Methods. 3: 833-8. PMID 16964256 DOI: 10.1038/Nmeth935 |
0.526 |
|
2006 |
Friedman A, Perrimon N. High-throughput approaches to dissecting MAPK signaling pathways. Methods (San Diego, Calif.). 40: 262-71. PMID 16844385 DOI: 10.1016/J.Ymeth.2006.05.002 |
0.573 |
|
2004 |
Friedman A, Perrimon N. Genome-wide high-throughput screens in functional genomics. Current Opinion in Genetics & Development. 14: 470-6. PMID 15380236 DOI: 10.1016/J.Gde.2004.07.010 |
0.561 |
|
Show low-probability matches. |